Spero Therapeutics, Inc. (SPRO)
2.74
-0.06
(-2.14%)
USD |
NASDAQ |
Apr 24, 16:00
2.75
+0.01
(+0.36%)
After-Hours: 20:00
Spero Therapeutics Total Assets (Quarterly) : 68.92M for Dec. 31, 2025
Total Assets (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Total Assets Definition
Assets are a main portion of the balance sheet of a company that measure things that provide economic value. A few examples of assets of a company include cash, inventories, and accounts receivable. From an accounting perspective, the balance sheet equation is Assets = Liabilities + Shareholder's Equity.
Total Assets (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Assets (Quarterly) Benchmarks
| SIGA Technologies, Inc. | 219.98M |
| SELLAS Life Sciences Group, Inc. | 78.34M |
| Nephros, Inc. | 13.64M |
| ACADIA Pharmaceuticals, Inc. | 1.564B |
| Alnylam Pharmaceuticals, Inc. | 5.026B |
Total Assets (Quarterly) Related Metrics
| Total Liabilities (Quarterly) | 9.898M |
| Shareholders Equity (Quarterly) | 59.02M |
| Debt to Equity Ratio | 0.0491 |
| Current Ratio | 7.588 |
| Net Debt Paydown Yield | 0.26% |